These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9823323)

  • 41. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
    Cleary I; Doherty G; Moran E; Clynes M
    Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump.
    Jedlitschky G; Leier I; Buchholz U; Barnouin K; Kurz G; Keppler D
    Cancer Res; 1996 Mar; 56(5):988-94. PubMed ID: 8640791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transport of the beta -O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog.
    Leslie EM; Ito K; Upadhyaya P; Hecht SS; Deeley RG; Cole SP
    J Biol Chem; 2001 Jul; 276(30):27846-54. PubMed ID: 11375986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins.
    Rappa G; Lorico A; Flavell RA; Sartorelli AC
    Cancer Res; 1997 Dec; 57(23):5232-7. PubMed ID: 9393740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export.
    Evers R; de Haas M; Sparidans R; Beijnen J; Wielinga PR; Lankelma J; Borst P
    Br J Cancer; 2000 Aug; 83(3):375-83. PubMed ID: 10917554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required.
    Leslie EM; Haimeur A; Waalkes MP
    J Biol Chem; 2004 Jul; 279(31):32700-8. PubMed ID: 15161912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multidrug resistance proteins and other drug transport-related resistance to natural product agents.
    Broxterman HJ; Giaccone G; Lankelma J
    Curr Opin Oncol; 1995 Nov; 7(6):532-40. PubMed ID: 8547402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.
    Nakamura T; Oka M; Aizawa K; Soda H; Fukuda M; Terashi K; Ikeda K; Mizuta Y; Noguchi Y; Kimura Y; Tsuruo T; Kohno S
    Biochem Biophys Res Commun; 1999 Feb; 255(3):618-24. PubMed ID: 10049760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug resistance-associated protein (MRP) mediated transport of daunomycin and leukotriene C4 (LTC4) in isolated plasma membrane vesicles.
    Ding GY; Shen T; Center MS
    Anticancer Res; 1999; 19(4B):3243-8. PubMed ID: 10652618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells.
    Ishikawa T; Bao JJ; Yamane Y; Akimaru K; Frindrich K; Wright CD; Kuo MT
    J Biol Chem; 1996 Jun; 271(25):14981-8. PubMed ID: 8663001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution.
    Breuninger LM; Paul S; Gaughan K; Miki T; Chan A; Aaronson SA; Kruh GD
    Cancer Res; 1995 Nov; 55(22):5342-7. PubMed ID: 7585598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function.
    Vanhoefer U; Yin MB; Harstrick A; Seeber S; Rustum YM
    Biochem Pharmacol; 1997 Mar; 53(6):801-9. PubMed ID: 9113101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells.
    Terashi K; Oka M; Soda H; Fukuda M; Kawabata S; Nakatomi K; Shiozawa K; Nakamura T; Tsukamoto K; Noguchi Y; Suenaga M; Tei C; Kohno S
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1697-700. PubMed ID: 10817732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of glucuronosyl etoposide transport by glutathione in multidrug resistance-associated protein-overexpressing cells.
    Sakamoto H; Hara H; Hirano K; Adachi T
    Cancer Lett; 1999 Jan; 135(1):113-9. PubMed ID: 10077229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
    Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
    Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
    Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
    Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ATP-dependent transport of reduced glutathione on YCF1, the yeast orthologue of mammalian multidrug resistance associated proteins.
    Rebbeor JF; Connolly GC; Dumont ME; Ballatori N
    J Biol Chem; 1998 Dec; 273(50):33449-54. PubMed ID: 9837923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
    Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion.
    Feller N; Broxterman HJ; Währer DC; Pinedo HM
    FEBS Lett; 1995 Jul; 368(2):385-8. PubMed ID: 7628644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.